By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cynapsus Therapeutics 

828 Richmond Street West

Toronto  Ontario  M6J 1C9  Canada
Phone: 416-703-2449 Fax: 416-703-8752


Cynapsus is a specialty pharmaceutical company developing a convenient and easy to use sublingual (oral) thin film strip for the acute rescue of “off” motor symptoms of Parkinson’s disease. Cynapsus’ drug candidate, APL-130277, is an easy-to-administer, fast-acting reformulation of apomorphine, which is the only approved drug (in the United States, Europe, Japan and other countries) to rescue patients from “off” episodes. Cynapsus is focused on maximizing the value of APL-130277 by completing pivotal studies in advance of a New Drug Application (“NDA”) expected to be submitted in 2016. The company is located in Toronto, ON.

Key Statistics

Ownership: Public

Web Site: Cynapsus
Employees: 10
Symbol: CYNA


Company News
Sunovion Completes Acquisition Of Cynapsus (CYNA) 10/21/2016 8:25:35 AM
Massachusetts' Sunovion Swallows Up Cynapsus (CYNA) in $624 Million Deal, Gains Experimental Parkinson's Drug 8/31/2016 3:48:27 PM
Cynapsus Therapeutics (CYNA) To Present At Noble Financial Capital Markets' Twelfth Annual Investor Conference 1/14/2016 9:15:32 AM
Cynapsus Therapeutics (CYNA) And Michael J. Fox Foundation Collaborate On Pilot Use Of Wearable Device And Data Science Approaches In Phase 3 Parkinson's Clinical Study 1/7/2016 6:33:02 AM
Cynapsus Therapeutics (CYNA) Completes Short-Form Amalgamation With Wholly-Owned Subsidiary 1/5/2016 8:13:02 AM
Cynapsus Therapeutics (CYNA) Announces Successful Completion Of Bioavailability And Pharmacokinetic Study And Provides Update On European Clinical Plans 12/11/2015 7:00:31 AM
Cynapsus Therapeutics (CYNA) Announces Positive Data Presentations At World Congress On Parkinson's Disease And Related Disorders Meeting 12/8/2015 10:06:05 AM
Cynapsus Therapeutics (CYNA) Expands Senior Leadership Team 11/20/2015 7:55:34 AM
Cynapsus Therapeutics (CYNA) To Present At Stifel 2015 Healthcare Conference 11/13/2015 10:09:15 AM
Cynapsus Therapeutics (CYNA) Reports Third Quarter 2015 Financial Results And Recent Developments 11/12/2015 7:22:39 AM